Research is exploring the potential of targeting pyrimidine metabolism in cancer treatment, particularly in the context of precision medicine. Studies have identified vulnerabilities in cancer cells related to pyrimidine synthesis, which may be exploited for therapeutic purposes. The approach is being investigated in various types of cancer, including lung cancer, brain tumors, and glioblastoma, with potential implications for overcoming therapeutic resistance.